Found 87 results
[ Author(Desc)] Title Type Year
Filters: Author is Luiz E Bermudez  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice., Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.
L. E. Bermudez, Young, L. S., and Inderlied, C. B., Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells., Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.
L. E. Bermudez, Wu, M., Enkel, H., and Young, L. S., Naturally occurring antibodies against Mycobacterium avium complex., Annals of clinical and laboratory science, vol. 19, no. 6, pp. 435-43, 1989.
L. E. Bermudez, Sangari, F. J., Kolonoski, P., Petrofsky, M., and Goodman, J., The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells., Infection and immunity, vol. 70, no. 1, pp. 140-6, 2002.
L. E. Bermudez and Petrofsky, M., Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells., Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.
L. E. Bermudez, Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma., Journal of immunology (Baltimore, Md. : 1950), vol. 150, no. 5, pp. 1838-45, 1993.
L. E. Bermudez, [Post-antibiotic effect in the treatment of infections in neutropenic patients]., Revista do Hospital das Clínicas, vol. 41, no. 2, pp. 76-9, 1986.
L. E. Bermudez and Petrofsky, M., Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells., Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.
L. E. Bermudez, Infection of "nonprofessional phagocytes" with Mycobacterium avium complex., Clinical immunology and immunopathology, vol. 61, no. 2 Pt 1, pp. 225-35, 1991.
L. E. Bermudez, Shelton, K., and Young, L. S., Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells., Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.
L. E. Bermudez and Young, L. S., Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex., Journal of leukocyte biology, vol. 48, no. 1, pp. 67-73, 1990.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease., Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez, Wu, M., and Young, L. S., Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin., The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice., Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
L. E. Bermudez, Danelishvili, L., and Early, J., Mycobacteria and Macrophage Apoptosis: Complex Struggle for Survival., Microbe Wash DC, vol. 1, no. 8, pp. 372-375, 2006.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice., The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S., Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages., Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, Petrofsky, M., and Shelton, K., Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection., Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.
L. E. Bermudez, Inderlied, C., and Young, L. S., Stimulation with cytokines enhances penetration of azithromycin into human macrophages., Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez and Young, L. S., Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex., Infection and immunity, vol. 62, no. 5, pp. 2021-6, 1994.
L. E. Bermudez and Young, L. S., Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex., Microbial pathogenesis, vol. 7, no. 4, pp. 289-98, 1989.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice., Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.
L. E. Bermudez, Goodman, J., and Petrofsky, M., Role of complement receptors in uptake of Mycobacterium avium by macrophages in vivo: evidence from studies using CD18-deficient mice., Infection and immunity, vol. 67, no. 9, pp. 4912-6, 1999.
L. E. Bermudez, Covaro, G., and Remington, J., Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors., Infection and immunity, vol. 61, no. 10, pp. 4126-30, 1993.

Pages